Tasso Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 110

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 22

Tasso General Information

Description

Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. The company's devices are disposable, small in size, and have an interchangeable cartridge to ensure that the right blood preparation starts as soon as the sample is taken, enabling patients to painlessly administer their blood samples and mail them back to the lab for analysis in a hassle-free manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 2nd Avenue West
  • 3rd Floor
  • Seattle, WA 98119
  • United States
+1 (206)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
TMT
Corporate Office
  • 400 2nd Avenue West
  • 3rd Floor
  • Seattle, WA 98119
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tasso Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC (Series B) 23-Nov-2021 Completed Generating Revenue
10. Later Stage VC (Series A) 22-Jul-2020 Completed Generating Revenue
9. Seed Round 05-Mar-2019 Completed Generating Revenue
8. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
7. Grant 21-Sep-2017 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
5. Grant 01-Jan-2016 Completed Generating Revenue
4. Grant 01-Jan-2015 $3.99M $1.5K Completed Generating Revenue
3. Grant 01-Jan-2014 $7.93M $1.5K Completed Generating Revenue
To view Tasso’s complete valuation and funding history, request access »

Tasso Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A 9,557,528 $0.000100 6% $1.78 $1.78 1x $1.78 13.99%
Seed 6,339,672 $0.000100 6% $0.98 $0.98 1x $0.98 9.28%
To view Tasso’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tasso Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. The company's devices
Diagnostic Equipment
Seattle, WA
110 As of 2025

Gland, Switzerland
 

Pleasanton, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tasso Competitors (5)

One of Tasso’s 5 competitors is HemaXis, a Venture Capital-Backed company based in Gland, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemaXis Venture Capital-Backed Gland, Switzerland
Vortex Biosciences Venture Capital-Backed Pleasanton, CA
YourBio Health Venture Capital-Backed Medford, MA
Spot On Sciences Private Equity-Backed Hayward, CA
Abaxis Formerly VC-backed Union City, CA
You’re viewing 5 of 5 competitors. Get the full list »

Tasso Patents

Tasso Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11633136-B2 Bodily fluid collection devices and related methods Active 26-Feb-2021
US-20220273208-A1 Bodily fluid collection devices and related methods Active 26-Feb-2021
AU-2022227019-A1 Bodily fluid collection devices and related methods Pending 26-Feb-2021
EP-4297648-A1 Bodily fluid collection devices and related methods Pending 26-Feb-2021
CA-3208470-A1 Bodily fluid collection devices and related methods Pending 26-Feb-2021 A61B5/15117
To view Tasso’s complete patent history, request access »

Tasso Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tasso Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Health Innovation Corporation Minority
InCube Ventures Corporate Venture Capital Minority
OMX Ventures Venture Capital Minority
RA Capital Management Venture Capital Minority
Senvest Capital Hedge Fund Minority
You’re viewing 5 of 22 investors. Get the full list »

Tasso FAQs

  • When was Tasso founded?

    Tasso was founded in 2012.

  • Where is Tasso headquartered?

    Tasso is headquartered in Seattle, WA.

  • What is the size of Tasso?

    Tasso has 110 total employees.

  • What industry is Tasso in?

    Tasso’s primary industry is Diagnostic Equipment.

  • Is Tasso a private or public company?

    Tasso is a Private company.

  • What is Tasso’s current revenue?

    The current revenue for Tasso is .

  • How much funding has Tasso raised over time?

    Tasso has raised $123M.

  • Who are Tasso’s investors?

    Global Health Innovation, InCube Ventures, OMX Ventures, RA Capital Management, and Senvest Capital are 5 of 22 investors who have invested in Tasso.

  • Who are Tasso’s competitors?

    HemaXis, Vortex Biosciences, YourBio Health, Spot On Sciences, and Abaxis are competitors of Tasso.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »